No Data
No Data
G-Next: Confirmation letter
G-Next: Securities Report - 23rd Fiscal Year (April 1, 2023 - March 31, 2024)
Stocks that moved the day before part1 include Teigaia, FP Partner, Qualipus, and others.
Stock name <Code> 24-day closing price ⇒ Previous day comparison Nova Leze <9160> 321 +25 TKP <3479> and capital business tie-up. Assointha <9340> 1,155 +82 announced the sale of dental engineering products "ZERO TUBE SYSTEM". Okura Works <4221> 2,849 +74 announced sales and share buybacks. Rentorax <6045> 455 +245 revenue in May increased by 33.3% and growth rate expanded from 5.0% increase in April. G-NEXT <4179>
Emerging Markets Update: Renascience continues to decline significantly, while Rentracks rebounds significantly.
<4179> G-NEXT 293 +10 rapid rebound. After the close of trading on the 21st, it was announced that the financial estimates for the fiscal year ending in March 2025, which had been undisclosed, were revenue of 610 to 670 million yen (610 million yen in the previous year) and operating loss of 100 to 140 million yen (loss of 148 million yen in the same period as the previous year). There is a possibility that sales will increase from the previous year, and it is considered a positive factor that it has shown the prospect of reducing operating losses. <4889> Rena science 3
Despite the downward pressure from softness and firmness in long-term US Treasury yields, the downside is expected to remain strong.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to have a weak development. In the U.S. stock market on the 21st, the Dow Jones Industrial Average rose slightly for the fourth consecutive day, up 15.57 dollars (+ 0.04%) to 39,150.33 dollars. While selling for profit adjustments of U.S. stock-related options, which concentrate on options expiration day, emerged, buying supported stocks that had a sense of delay. On the other hand, following the previous day, Nvidia and Micron Technology, both of which deal with semiconductors, were sold for Nasdaq, down 0.18%.
Asukanet, Renascience, and others.
<2438> Asukanet conducts a share buyback of up to 340,000 shares (2.07% of the issued shares) for purchase on ToSTNeT-3 on the 24th. <3479> TKP Nova and <9160> Maika enter into a capital and business alliance, while <4179> G Next signs a basic agreement for a capital and business partnership candidate joint development that handles consulting related to corporate governance. <4889> Renascience deals with pyridoxine for premenstrual syndrome / premenstrual dysphoric disorder with psychotic symptoms.
No Data